Similar results were confirmed by Zhang et al.,41 MAGE‐1 and MAGE‐3 had high expression rates of 53.7% and 36.6%, while GAGE‐1/2 and BAGE had lower rates of 26.8% and 14.6% in ovarian cancer tissues. Here, MAGEA3 is linked to ovarian carcinoma.